Mary T. Szela, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 51,101 shares at $54.33 ($2.8M) on 2011-12-14, disclosed to the SEC on 2011-12-16.
Open-market sale of $2.8M ABT by Senior Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.33 | 300 | $16K | 0.6% |
| 2 | $54.33 | 500 | $27K | 1.0% |
| 3 | $54.33 | 2,500 | $136K | 4.9% |
| 4 | $54.34 | 100 | $5K | 0.2% |
| 5 | $54.34 | 200 | $11K | 0.4% |
| 6 | $54.35 | 1,550 |
| $84K |
| 3.0% |
| 7 | $54.35 | 900 | $49K | 1.8% |
| 8 | $54.36 | 2,100 | $114K | 4.1% |
| 9 | $54.37 | 900 | $49K | 1.8% |
| 10 | $54.37 | 100 | $5K | 0.2% |
| 11 | $54.38 | 5,500 | $299K | 10.8% |
| 12 | $54.38 | 5,195 | $283K | 10.2% |
| 13 | $54.39 | 1,900 | $103K | 3.7% |
| 14 | $54.39 | 100 | $5K | 0.2% |
| 15 | $54.39 | 1,600 | $87K | 3.1% |
| 16 | $54.40 | 3,700 | $201K | 7.2% |
| 17 | $54.40 | 4,500 | $245K | 8.8% |
| 18 | $54.41 | 2,300 | $125K | 4.5% |
| 19 | $54.41 | 5,275 | $287K | 10.3% |
| 20 | $54.42 | 2,488 | $135K | 4.9% |
| 21 | $54.43 | 2,700 | $147K | 5.3% |
| 22 | $54.43 | 212 | $12K | 0.4% |
| 23 | $54.44 | 3,200 | $174K | 6.3% |
| 24 | $54.45 | 2,781 | $151K | 5.4% |
| 25 | $54.46 | 500 | $27K | 1.0% |
| Total | $54.40 avg | 51,101 | $2.8M | 100% |
| Filing → |
| TLSI | SELL | 2026-03-20 | $79K | — | Filing → |
| TLSI | BUY | 2026-02-23 | $125K | — | Filing → |
| TLSI | BUY | 2025-01-31 | $52K | — | Filing → |